Process for the preparation of a composition of genetically modified hematopoietic progenitor cells

US7994144B2 · kind B2 · utility

Assignee

• JOHNSON & JOHNSON RESEARCH PTY. LIMITED · AU

Inventors

• Geoffrey Phillip Symonds · Mandurah, AU
• Rafael Amado · Westlake Village, US
• Lun-Quan Sun · Sydney, AU
• Janet Lesley Macpherson · Sydney, AU
• Greg Fanning · Sydney, AU
• Wayne Gerlach · Acacia Hills, AU

Key dates

• Filing date: Jul 10, 2002
• Grant date: Aug 9, 2011
• Expiry date: Apr 1, 2025

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2310/14
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Described are compositions and methods relating to gene therapy, particularly as applied to hematopoietic progenitor (HP) cells, to transduced cells and methods of obtaining them, and to methods of using them to provide prolonged engraftment of modified hematopoietic cells in human subjects. The invention particularly relates to ex vivo gene therapy of HP cells for treatment or prevention of HIV infection.